conditioning regimens for allogeneic stem cell transplantation therapy (DBCOND0020486)

Identifiers

Synonyms
Conditioning regimens for allogeneic stem cell transplantation / Hematopoietic stem cell transplant conditioning therapy / Hematopoietic stem cell transplant conditioning / Bone marrow conditioning therapy / Bone marrow conditioning / Bone marrow conditioning regimen

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Alemtuzumab
A monoclonal anti-CD52 antibody used in the treatment of B-cell chronic lymphocytic leukemia and relapsing forms of multiple sclerosis.
Busulfan
An alkylating agent used to treat chronic myelogenous leukemia.
Carboplatin
A alkylating agent used to treat advanced ovarian cancer.
Melphalan
An alkylating agent used to treat multiple myeloma, ovarian carcinoma, uveal melanoma with unresectable hepatic metastases, and for high-dose conditioning before hematopoietic stem cell transplant in patients.
Clinical Trials
Not Available